MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 i 4500
001 in00004414913
006 m o d f
007 cr |||||||||||
008 210129s2021 dcua ob f000 0 eng c
005 20220810160939.5
019 |a 1237322777 
035 |a (OCoLC)on1233296597 
040 |a GPO  |b eng  |e rda  |e pn  |c GPO  |d OCLCO  |d OCLCF  |d OCLCO  |d OCLCQ  |d S2H  |d GPO  |d MvI 
042 |a pcc 
043 |a n-us--- 
049 |a WWW 
050 4 |a RA644.C67  |b .U554 2021 
074 |a 0546-D (online) 
086 0 |a GA 1.13:GAO-21-265 
088 |a GAO-21-265 
110 1 |a United States.  |b Government Accountability Office,  |e author. 
245 1 0 |a COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention :  |b report to congressional committees. 
264 1 |a [Washington, D.C.] :  |b United States Government Accountability Office,  |c 2021. 
300 |a 1 online resource (vii, 333 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a "January 2021." 
500 |a "GAO-21-265." 
500 |a GPO Cataloging Record Distribution Program (CRDP). 
504 |a Includes bibliographical references. 
588 |a Description based on online resource, PDF version; title from cover (GAO, viewed Jan. 28, 2021). 
610 1 0 |a United States.  |t Consolidated Appropriations Act, 2021. 
610 1 0 |a United States.  |t Coronavirus Aid, Relief, and Economic Security Act. 
650 0 |a COVID-19 (Disease)  |x Vaccination  |z United States  |x Planning. 
650 0 |a COVID-19 (Disease)  |x Economic aspects  |z United States. 
650 0 |a COVID-19 (Disease)  |x Diagnosis  |z United States. 
650 0 |a COVID-19 (Disease)  |z United States  |x Prevention. 
650 0 |a COVID-19 (Disease)  |x Treatment  |z United States. 
650 0 |a Vaccines industry  |x Government policy  |z United States. 
650 0 |a Vaccines  |x Development  |z United States. 
650 0 |a Public health administration  |z United States. 
651 0 |a United States  |x Appropriations and expenditures. 
650 7 |a COVID-19 (Disease)  |x Diagnosis.  |2 fast  |0 (OCoLC)fst01984644 
650 7 |a COVID-19 (Disease)  |x Economic aspects.  |2 fast  |0 (OCoLC)fst02021810 
650 7 |a COVID-19 (Disease)  |x Prevention.  |2 fast  |0 (OCoLC)fst02021842 
650 7 |a COVID-19 (Disease)  |x Treatment.  |2 fast  |0 (OCoLC)fst01984645 
650 7 |a Expenditures, Public.  |2 fast  |0 (OCoLC)fst00918345 
650 7 |a Public health administration.  |2 fast  |0 (OCoLC)fst01082334 
650 7 |a Vaccines industry  |x Government policy.  |2 fast  |0 (OCoLC)fst01163594 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
856 4 0 |u https://purl.fdlp.gov/GPO/gpo150784  |t 0 
999 f f |s b34c6770-a94b-47fa-8e75-7b343a9439f4  |i c93191f3-b551-31f6-ab05-7aa71cd130fa  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e GA 1.13:GAO-21-265  |h Superintendent of Documents classification 
998 f f |a GA 1.13:GAO-21-265  |t 0  |l Available Online